Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme

Public Health

Volumn 126, Issue 12, 2012, Pages 1075-1077

  Smailyte, G ^a   Aleknaviciene, B ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Incidence; Population based programme; Prostate cancer; PSA testing

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; LITHUANIA; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PROSTATE CANCER; SCREENING TEST; HEALTH CARE QUALITY; INCIDENCE; METHODOLOGY; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; REGISTER;

ADULT; AGED; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; LITHUANIA; MALE; MIDDLE AGED; PROGRAM EVALUATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES;

EID: 84857437113     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2012.01.016     Document Type: Article

References (12)

1. Jankevicius, F., Adomaitis, R., Jievaltas, M., Ulys, A., Kurtinaitis, J., The launch of the Lithuanian Early Prostate Cancer Detection Program (EPCDP). Eur Urol Suppl, 6, 2007, 174.
2. Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L., Thomas, D.B., (eds.) Cancer incidence in five continents, vol. VIII, 2002, International Agency for Research on Cancer, Lyon.
3. Curado, M.P., Edwards, B., Shin, H.R., et al. (eds.) Cancer incidence in five continents, vol. IX, 2007, International Agency for Research on Cancer, Lyon.
4. Bray, F., Lortet-Tieulent, J., Ferlay, J., Forman, D., Auvinen, A., Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 46 (2010), 3040–3052.
5. Lu-Yao, G.L., Greenberg, E.R., Changes in prostate cancer incidence and treatment in USA. Lancet 343 (1994), 251–254.
6. Threlfall, T.J., English, D.R., Rouse, I.L., Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996. Med J Aust 169 (1998), 21–24.
7. Vutuc, C., Waldhoer, T., Lunglmayr, G., Hoeltl, W., Haidinger, G., PSA testing in Austria: induced morbidity and saved mortality. Eur J Cancer Prev 18 (2009), 377–380.
8. Crocetti, E., Ciatto, S., Buzzoni, C., Zappa, M., Prostate cancer incidence rates have started to decrease in central Italy. J Med Screen 17 (2010), 50–51.
9. Collin, S.M., Martin, R.M., Metcalfe, C., Gunnell, D., Albertsen, P.C., Neal, D., et al. Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study. Lancet Oncol 9 (2008), 445–452.
10. Bartsch, G., Horninger, W., Klocker, H., Pelzer, A., Bektic, J., Oberaigner, W., et al. Tyrol Prostate Cancer Screening Group. Tyrol prostate cancer demonstration project: early detection, treatment, outcome, incidence and mortality. BJU Int 101 (2008), 809–816.
11. Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, Buys, S.S., Chia, D., Church, T.R., et al. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009), 1310–1319.
12. Schröder, F.H., Hugosson, J., Roobol, M.J., Tammela, T.L., Ciatto, S., Nelen, V., et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009), 1320–1328.